FDA approves injectable monoclonal antibody for severe asthma

The US Food and Drug Administration has approved mepolizumab (GlaxoSmithKline’s Nucala), a humanized interleukin-5 antagonist monoclonal antibody, for use with other drugs to treat asthma in patients aged 12 years and over.…